Literature DB >> 26461168

Sex differences in cannabis withdrawal symptoms among treatment-seeking cannabis users.

Evan S Herrmann1, Elise M Weerts2, Ryan Vandrey1.   

Abstract

Over 300,000 individuals enter treatment for cannabis-use disorders (CUDs) in the United States annually. Cannabis withdrawal is associated with poor CUD-treatment outcomes, but no prior studies have examined sex differences in withdrawal among treatment-seeking cannabis users. Treatment-seeking cannabis users (45 women and 91 men) completed a Marijuana Withdrawal Checklist (Budney, Novy, & Hughes, 1999, Budney, Moore, Vandrey, & Hughes, 2003) at treatment intake to retrospectively characterize withdrawal symptoms experienced during their most recent quit attempt. Scores from the 14-item Composite Withdrawal Discomfort Scale (WDS), a subset of the Marijuana Withdrawal Checklist that corresponds to valid cannabis withdrawal symptoms described in the Diagnostic and Statistical Manual of Mental Disorders (5th ed.; APA, 2013) were calculated. Demographic and substance-use characteristics, overall WDS scores, and scores on individual WDS symptoms were compared between women and men. Women had higher overall WDS scores than men, and women had higher scores than men on 6 individual symptoms in 2 domains, mood symptoms (i.e., irritability, restlessness, increased anger, violent outbursts), and gastrointestinal symptoms (i.e., nausea, stomach pain). Follow-up analyses isolating the incidence and severity of WDS symptoms demonstrated that women generally reported a higher number of individual withdrawal symptoms than men, and that they reported experiencing some symptoms as more severe. This is the first report to demonstrate that women seeking treatment for CUDs may experience more withdrawal then men during quit attempts. Prospective studies of sex differences in cannabis withdrawal are warranted. (PsycINFO Database Record (c) 2015 APA, all rights reserved).

Entities:  

Mesh:

Year:  2015        PMID: 26461168      PMCID: PMC4747417          DOI: 10.1037/pha0000053

Source DB:  PubMed          Journal:  Exp Clin Psychopharmacol        ISSN: 1064-1297            Impact factor:   3.157


  39 in total

1.  Clinical profile of participants in a brief intervention program for cannabis use disorder.

Authors:  J Copeland; W Swift; V Rees
Journal:  J Subst Abuse Treat       Date:  2001-01

2.  Marijuana withdrawal among adults seeking treatment for marijuana dependence.

Authors:  A J Budney; P L Novy; J R Hughes
Journal:  Addiction       Date:  1999-09       Impact factor: 6.526

Review 3.  Smoking cessation in women. Special considerations.

Authors:  K A Perkins
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

4.  Reliability of the Timeline Followback for cocaine, cannabis, and cigarette use.

Authors:  Sean M Robinson; Linda Carter Sobell; Mark B Sobell; Gloria I Leo
Journal:  Psychol Addict Behav       Date:  2012-12-31

Review 5.  V. Stress and irritable bowel syndrome.

Authors:  E A Mayer; B D Naliboff; L Chang; S V Coutinho
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2001-04       Impact factor: 4.052

6.  Opioid-, cannabis- and alcohol-dependent women show more rapid progression to substance abuse treatment.

Authors:  Carlos A Hernandez-Avila; Bruce J Rounsaville; Henry R Kranzler
Journal:  Drug Alcohol Depend       Date:  2004-06-11       Impact factor: 4.492

7.  The time course and significance of cannabis withdrawal.

Authors:  Alan J Budney; Brent A Moore; Ryan G Vandrey; John R Hughes
Journal:  J Abnorm Psychol       Date:  2003-08

8.  Cannabinoid receptors in rat brain areas: sexual differences, fluctuations during estrous cycle and changes after gonadectomy and sex steroid replacement.

Authors:  F Rodríguez de Fonseca; M Cebeira; J A Ramos; M Martín; J J Fernández-Ruiz
Journal:  Life Sci       Date:  1994       Impact factor: 5.037

9.  Meta-analysis of the efficacy of nicotine replacement therapy for smoking cessation: differences between men and women.

Authors:  Antonio Cepeda-Benito; Jose T Reynoso; Stephen Erath
Journal:  J Consult Clin Psychol       Date:  2004-08

10.  Gender differences in smoking cessation in a placebo-controlled trial of bupropion with behavioral counseling.

Authors:  Bradley N Collins; E Paul Wileyto; Freda Patterson; Margaret Rukstalis; Janet Audrain-McGovern; Vyga Kaufmann; Angela Pinto; Larry Hawk; Raymond Niaura; Leonard H Epstein; Caryn Lerman
Journal:  Nicotine Tob Res       Date:  2004-02       Impact factor: 4.244

View more
  35 in total

1.  Precipitated Δ9-THC withdrawal reduces motivation for sucrose reinforcement in mice.

Authors:  M L Eckard; K R Trexler; B T Kotson; K G Anderson; S G Kinsey
Journal:  Pharmacol Biochem Behav       Date:  2020-06-09       Impact factor: 3.533

2.  Gender differences among treatment-seeking adults with cannabis use disorder: Clinical profiles of women and men enrolled in the achieving cannabis cessation-evaluating N-acetylcysteine treatment (ACCENT) study.

Authors:  Brian J Sherman; Aimee L McRae-Clark; Nathaniel L Baker; Susan C Sonne; Therese K Killeen; Kasie Cloud; Kevin M Gray
Journal:  Am J Addict       Date:  2017-02-02

3.  Does Marijuana Contribute to Intimate Partner Aggression? Temporal Effects in a Community Sample of Marijuana-Using Couples.

Authors:  Maria Testa; Jaye L Derrick; Weijun Wang; Kenneth E Leonard; Audrey Kubiak; Whitney C Brown; R Lorraine Collins
Journal:  J Stud Alcohol Drugs       Date:  2018-05       Impact factor: 2.582

4.  DSM-5 cannabis withdrawal syndrome: Demographic and clinical correlates in U.S. adults.

Authors:  Ofir Livne; Dvora Shmulewitz; Shaul Lev-Ran; Deborah S Hasin
Journal:  Drug Alcohol Depend       Date:  2018-10-22       Impact factor: 4.492

5.  Exogenous progesterone for cannabis withdrawal in women: Feasibility trial of a novel multimodal methodology.

Authors:  Brian J Sherman; Margaret A Caruso; Aimee L McRae-Clark
Journal:  Pharmacol Biochem Behav       Date:  2019-01-31       Impact factor: 3.533

6.  Sex differences in antinociceptive response to Δ-9-tetrahydrocannabinol and CP 55,940 in the mouse formalin test.

Authors:  Rebecca A LaFleur; Ronald P Wilson; Daniel J Morgan; Angela N Henderson-Redmond
Journal:  Neuroreport       Date:  2018-04-11       Impact factor: 1.837

Review 7.  Sex-Dependent Effects of Cannabis and Cannabinoids: A Translational Perspective.

Authors:  Ziva D Cooper; Rebecca M Craft
Journal:  Neuropsychopharmacology       Date:  2017-07-17       Impact factor: 7.853

8.  Prolonged cannabis withdrawal in young adults with lifetime psychiatric illness.

Authors:  Randi Melissa Schuster; Madeleine Fontaine; Emily Nip; Haiyue Zhang; Ailish Hanly; A Eden Evins
Journal:  Prev Med       Date:  2017-02-27       Impact factor: 4.018

9.  Sex differences in stress reactivity after intranasal oxytocin in recreational cannabis users.

Authors:  Stephanie C Reed; Margaret Haney; Jeanne Manubay; Bianca R Campagna; Brian Reed; Richard W Foltin; Suzette M Evans
Journal:  Pharmacol Biochem Behav       Date:  2018-12-04       Impact factor: 3.533

Review 10.  Use of Cannabidiol for the Treatment of Anxiety: A Short Synthesis of Pre-Clinical and Clinical Evidence.

Authors:  Madison Wright; Patricia Di Ciano; Bruna Brands
Journal:  Cannabis Cannabinoid Res       Date:  2020-09-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.